Literature DB >> 3165250

Immunohistochemical study of osteonectin in various types of osteosarcoma.

A Schulz1, G Jundt, K H Berghäuser, P Gehron-Robey, J D Termine.   

Abstract

Polyclonal antibodies against osteonectin, a 32 kd non-collagenous bone protein, were applied for the histogenetic identification of variously differentiated osteosarcoma tissues. A strong positive reaction was found in matrix-producing osteosarcoma cells of the osteoblastic type, but pleomorphic or fibrosarcomatous osteosarcoma tissues reacted focally positive as well. Because the production of osteonectin depends on the osteoblastlike function of the individual tumor cell, a homogeneous immunocytochemical staining of all tumor cells cannot be expected. Nevertheless, the immunocytochemical demonstration of osteonectin in osteolytic tumors that produce no or scarcely any matrix seems to be a valuable tool for establishment of their osteogenic origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165250      PMCID: PMC1880732     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  11 in total

1.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone.

Authors:  P A Price; A A Otsuka; J W Poser; J Kristaponis; N Raman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Imidazole increases the sensitivity of the cytochemical reaction for peroxidase with diaminobenzidine at a neutral pH.

Authors:  W Straus
Journal:  J Histochem Cytochem       Date:  1982-05       Impact factor: 2.479

Review 4.  Localization of collagen types in tissues.

Authors:  K von der Mark
Journal:  Int Rev Connect Tissue Res       Date:  1981

5.  Osteonectin, a bone-specific protein linking mineral to collagen.

Authors:  J D Termine; H K Kleinman; S W Whitson; K M Conn; M L McGarvey; G R Martin
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

6.  Small-cell osteosarcoma.

Authors:  S E Martin; A Dwyer; J M Kissane; J Costa
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

7.  [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].

Authors:  A Schulz; H P Fischer; H Breithaupt; H Pralle
Journal:  Onkologie       Date:  1983-12

8.  Osteonectin--a differentiation marker of bone cells.

Authors:  G Jundt; K H Berghäuser; J D Termine; A Schulz
Journal:  Cell Tissue Res       Date:  1987-05       Impact factor: 5.249

9.  Immunhistochemical demonstration of different collagen types in the normal epiphyseal plate and in benign and malignant tumors of bone and cartilage.

Authors:  K Remberger; S Gay
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-10

Review 10.  Chromosome mapping of connective tissue protein genes.

Authors:  R L Church
Journal:  Int Rev Connect Tissue Res       Date:  1981
View more
  8 in total

1.  Immunoelectron microscopy of osteonectin and type I collagen in osteoblasts and bone matrix.

Authors:  R Romanowski; G Jundt; J D Termine; K von der Mark; A Schulz
Journal:  Calcif Tissue Int       Date:  1990-06       Impact factor: 4.333

Review 2.  The hepatic extracellular matrix. I. Components and distribution in normal liver.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 3.  SPARC: a key player in the pathologies associated with obesity and diabetes.

Authors:  Katarina Kos; John P H Wilding
Journal:  Nat Rev Endocrinol       Date:  2010-03-02       Impact factor: 43.330

4.  Phalangeal intraosseous well-differentiated osteosarcoma of the hand.

Authors:  I Sugano; Y Tajima; Y Ishida; T Nagao; K Nagao; N Saga; T Ohno; E Miyakawa
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

5.  Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.

Authors:  G Jundt; A Schulz; K H Berghäuser; L W Fisher; P Gehron-Robey; J D Termine
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  SPARC is a source of copper-binding peptides that stimulate angiogenesis.

Authors:  T F Lane; M L Iruela-Arispe; R S Johnson; E H Sage
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

Review 7.  Exercise-induced myokines in health and metabolic diseases.

Authors:  Byunghun So; Hee-Jae Kim; Jinsoo Kim; Wook Song
Journal:  Integr Med Res       Date:  2014-10-05

8.  KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.

Authors:  Lucen Jiang; Jianghuan Liu; Qingzhu Wei; Yiyang Wang
Journal:  Diagn Pathol       Date:  2020-11-11       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.